WT1 peptide cancer vaccine composition for mucosal administration

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10206985
APP PUB NO 20140220059A1
SERIAL NO

14166970

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a cancer vaccine composition for mucosal administration for inducing cellular immunity, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a cellular immunity induction promoter. The composition efficiently induces cellular immunity against a cancer in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NITTO DENKO CORPORATION; OSAKA UNIVERSITY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Asari, Daisuke Osaka, JP 51 236
Hori, Mitsuhiko Osaka, JP 64 328
Maeda, Yoshiki Osaka, JP 33 269
Matsushita, Kyohei Osaka, JP 29 114
Okazaki, Arimichi Osaka, JP 28 213
Okubo, Katsuyuki Osaka, JP 37 420
Sugiyama, Haruo Osaka, JP 113 1386

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 19, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 19, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00